We are live on ! Find out more
VA

Verdad Advisers Portfolio holdings

AUM $88.8M
This Fund
S&P 500
This Quarter Est. Return
+13.25%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$88.8M
AUM Growth
+$1.45M
Cap. Flow
-$2.06M
Cap. Flow %
-2.32%
Top 10 Hldgs %
21.25%
Holding
237
New
133
Increased
18
Reduced
23
Closed
58

Top Buys

1
ATHM icon
Autohome
ATHM
+$2.49M
2
BLTE
Belite Bio
BLTE
+$2.32M
3
RVMD icon
Revolution Medicines
RVMD
+$2.18M
4
STT icon
State Street
STT
+$2.13M
5
ZYME icon
Zymeworks
ZYME
+$1.96M

Top Sells

1
C icon
Citigroup
C
+$4.03M
2
TJX icon
TJX Companies
TJX
+$3.81M
3
JNJ icon
Johnson & Johnson
JNJ
+$2.79M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.66M
5
CVX icon
Chevron
CVX
+$2.55M

Sector Composition

1 Healthcare 41.87%
2 Technology 13.22%
3 Financials 10.56%
4 Consumer Discretionary 7.94%
5 Communication Services 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLTE
1
Belite Bio
BLTE
$6.02B
$2.2M 2.48%
+13,813
New +$2.32M
STT icon
2
State Street
STT
$50.5B
$2.11M 2.37%
+16,665
New +$2.13M
ATHM icon
3
Autohome
ATHM
$2.48B
$2.11M 2.37%
+121,317
New +$2.49M
RVMD icon
4
Revolution Medicines
RVMD
$39.6B
$2.1M 2.36%
+21,572
New +$2.18M
ZYME icon
5
Zymeworks
ZYME
$1.78B
$2.07M 2.33%
+82,698
New +$1.96M
CALM icon
6
Cal-Maine
CALM
$4.2B
$1.95M 2.2%
24,637
+3,986
+19% +$327K
ZM icon
7
Zoom
ZM
$26.7B
$1.73M 1.95%
21,580
+649
+3% +$54.4K
CRC icon
8
California Resources
CRC
$4.69B
$1.56M 1.75%
22,500
+15,320
+213% +$867K
TENX icon
9
Tenax Therapeutics
TENX
$420M
$1.52M 1.72%
+95,330
New +$1.29M
ACAD icon
10
Acadia Pharmaceuticals
ACAD
$4.38B
$1.52M 1.71%
+68,290
New +$1.63M
PARR icon
11
Par Pacific Holdings
PARR
$3.82B
$1.41M 1.59%
+22,500
New +$1.01M
JNJ icon
12
Johnson & Johnson
JNJ
$609B
$1.32M 1.49%
5,418
-11,990
-69% -$2.79M
MU icon
13
Micron Technology
MU
$959B
$1.3M 1.46%
3,841
-2,945
-43% -$1.15M
NRIX icon
14
Nurix Therapeutics
NRIX
$2.4B
$1.29M 1.46%
+83,425
New +$1.38M
CMCSA icon
15
Comcast
CMCSA
$85B
$1.19M 1.34%
41,549
-56,847
-58% -$1.7M
AHCO icon
16
AdaptHealth
AHCO
$1.49B
$1.13M 1.27%
+95,000
New +$972K
CTNM
17
Contineum Therapeutics
CTNM
$532M
$1.12M 1.26%
+86,032
New +$1.15M
LRCX icon
18
Lam Research
LRCX
$392B
$1.1M 1.24%
5,163
-10,308
-67% -$2.3M
CLDT
19
Chatham Lodging
CLDT
$624M
$1.1M 1.24%
140,000
+25,000
+22% +$186K
BNY
20
Bank of New York Mellon
BNY
$108B
$1.06M 1.2%
8,951
-5,810
-39% -$691K
AXSM icon
21
Axsome Therapeutics
AXSM
$11.8B
$1.01M 1.14%
+5,971
New +$1.03M
CLYM
22
Climb Bio
CLYM
$727M
$990K 1.11%
+144,540
New +$834K
AMAT icon
23
Applied Materials
AMAT
$421B
$989K 1.11%
+2,894
New +$973K
DSGN icon
24
Design Therapeutics
DSGN
$785M
$982K 1.11%
+92,310
New +$934K
JLL icon
25
Jones Lang LaSalle
JLL
$15.3B
$963K 1.08%
3,163
+2,473
+358% +$799K
1
2 3 4 5

Similar funds

CAM
Capital Asset Management Denver, Colorado $88.8M AUM
SCA
Sassicaia Capital Advisers Jericho, New York $88.8M AUM 146.47% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $88.7M AUM 25.11% 1-Year Est. Return
XFP
Xena Financial Planning Portland, Oregon $88.6M AUM
UCM
Up Capital Management Roseville, California $89.1M AUM
BLC
Blue Line Capital Chicago, Illinois $88.4M AUM
BC
Bayforest Capital London, United Kingdom $89.3M AUM 33.7% 1-Year Est. Return

Verdad Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, Verdad Advisers held 237 positions worth $88.8M, up 1.7% from $87.4M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Verdad Advisers's Q1 2026 filing shows 133 new, 18 increased, 23 reduced and 58 closed positions. Its largest new stake was Autohome: 121,317 shares worth $2.11M. The largest sale was Citigroup, an estimated $4.03M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

  • Verdad Advisers's largest Q1 2026 buy was Autohome: 121,317 shares worth $2.11M.
  • Verdad Advisers added most to California Resources in Q1 2026, an estimated $867K increase.
  • Verdad Advisers's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $2.79M.
  • Verdad Advisers fully exited Citigroup in Q1 2026, selling an estimated $4.03M.
  • Verdad Advisers's ten largest holdings make up 21% of its $88.8M portfolio in Q1 2026.
  • Verdad Advisers opened 133 new positions and closed 58 in Q1 2026.
  • Verdad Advisers's portfolio value rose 1.7% quarter-over-quarter to $88.8M.

Based on Verdad Advisers's 13F filing for Q1 2026, filed 15 May 2026.